Several smaller telehealth companies that previously offered compounded GLP-1 drugs have already shut down
The parenteral GLP-1 receptor agonist market is projected to grow by $47,567 million, the GLP-1 receptor agonists for hospitals market by $43,598 million, and the semaglutide-based GLP-1 receptor agonist market by $38,238 million over the next five years from 2025 to 2030
So they just wanna eat like a cracker because that's easy and easy to digest
Clinical studies have demonstrated increased dermal density and better overall skin remodeling
No apparent cause of the seizure (e.g., no acute, structural, or toxic-metabolic cause)
Symptoms like rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, and trouble breathing require immediate medical attention